Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$1.13B |
| 2 |
AT&T
T
|
+$275M |
| 3 |
Apple
AAPL
|
+$248M |
| 4 |
Walt Disney
DIS
|
+$235M |
| 5 |
Nike
NKE
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.4B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.17B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$863M |
| 4 |
Advanced Micro Devices
AMD
|
+$808M |
| 5 |
Amazon
AMZN
|
+$783M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.82% |
| 2 | Technology | 1.6% |
| 3 | Consumer Discretionary | 1.3% |
| 4 | Financials | 0.99% |
| 5 | Communication Services | 0.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCC
3201
CALL
CCC Intelligent Solutions
CCC
$4.41B
| $6.83M | ﹤0.01% |
600,000
+214,600
| +56% | +$2.5M |
|
|
PRFT
3202
DELISTED
Perficient Inc
PRFT
| $6.83M | ﹤0.01% |
52,826
-11,623
| -18% | -$1.53M |
|
3203
PUT
TG Therapeutics
TGTX
$8.26B
| $6.83M | ﹤0.01% |
359,400
+45,900
| +15% | +$1.19M |
|
3204
Janus Henderson Short Duration Income ETF
VNLA
$3.41B
| $6.83M | ﹤0.01% |
137,769
+129,848
| +1,639% | +$6.48M |
|
3205
Infosys
INFY
$48.8B
| $6.82M | ﹤0.01% |
+269,531
| New | +$6.26M |
|
3206
CALL
Radware
RDWR
$1.2B
| $6.82M | ﹤0.01% |
163,800
+145,300
| +785% | +$4.94M |
|
3207
Transocean
RIG
$6.48B
| $6.82M | ﹤0.01% |
2,471,555
-1,175,513
| -32% | -$3.99M |
|
3208
State Street SPDR S&P Biotech ETF
XBI
$11.3B
| $6.82M | ﹤0.01% |
60,893
-216,214
| -78% | -$26.1M |
|
|
CTLT
3209
DELISTED
CATALENT, INC.
CTLT
| $6.81M | ﹤0.01% |
53,213
+22,650
| +74% | +$2.91M |
|
3210
Innovative Industrial Properties
IIPR
$1.55B
| $6.81M | ﹤0.01% |
25,912
-17,731
| -41% | -$4.55M |
|
|
PPLI
3211
PUT
People Inc
PPLI
$2.91B
| $6.81M | ﹤0.01% |
63,510
-32,060
| -34% | -$3.62M |
|
3212
PUT
MKS Inc
MKSI
$17.3B
| $6.81M | ﹤0.01% |
39,100
+12,300
| +46% | +$1.92M |
|
3213
PUT
Concentrix
CNXC
$1.79B
| $6.8M | ﹤0.01% |
38,100
+8,400
| +28% | +$1.5M |
|
|
PBCT
3214
CALL
DELISTED
People's United Financial Inc
PBCT
| $6.8M | ﹤0.01% |
381,400
+21,200
| +6% | +$378K |
|
3215
Weyerhaeuser
WY
$17B
| $6.78M | ﹤0.01% |
164,630
-31,738
| -16% | -$1.21M |
|
3216
BridgeBio Pharma
BBIO
$15B
| $6.78M | ﹤0.01% |
406,331
+355,718
| +703% | +$15M |
|
|
ATH
3217
PUT
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $6.78M | ﹤0.01% |
81,300
+37,200
| +84% | +$3.05M |
|
3218
Fulgent Genetics
FLGT
$540M
| $6.77M | ﹤0.01% |
67,311
-46,951
| -41% | -$4.13M |
|
3219
PUT
Sundial Growers
SNDL
$336M
| $6.77M | ﹤0.01% |
1,166,700
+194,110
| +20% | +$1.27M |
|
3220
CALL
iShares US Medical Devices ETF
IHI
$3.41B
| $6.76M | ﹤0.01% |
102,600
-17,700
| -15% | -$1.13M |
|
3221
CALL
Coursera
COUR
$1.71B
| $6.74M | ﹤0.01% |
275,900
+40,900
| +17% | +$1.24M |
|
|
SLI
3222
Standard Lithium
SLI
$629M
| $6.74M | ﹤0.01% |
687,371
+476,397
| +226% | +$4.66M |
|
3223
PUT
Perion Network
PERI
$382M
| $6.74M | ﹤0.01% |
280,300
+134,700
| +93% | +$3.29M |
|
3224
Globalstar
GSAT
$10.6B
| $6.74M | ﹤0.01% |
387,249
+43,429
| +13% | +$952K |
|
3225
Outdoor Holding Co
POWW
$253M
| $6.73M | ﹤0.01% |
1,235,316
+63,125
| +5% | +$386K |
|
Similar funds
Jeff Yass's Q4 2021 Portfolio in Review
As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
- Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
- Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
- Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
- Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
- Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
- Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.
Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.